Thomas Wakim
Stock Analyst at Bell Potter
(0.09)
# 4,544
Out of 4,592 analysts
105
Total ratings
29.5%
Success rate
-17.5%
Average return
Main Sectors:
Stocks Rated by Thomas Wakim
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ASX: CSL CSL Limited | Maintained: Hold | $100.00 → $120.00 | $123.06 | -2.49% | 10 | Jul 31, 2026 | |
| ASX: PYC PYC Therapeutics Limited | Maintained: Buy | $2.30 | $1.70 | +35.29% | 8 | Jul 30, 2026 | |
| ASX: SNT Syntara Limited | Maintained: Buy | $0.06 | $0.03 | +140.00% | 7 | Jul 28, 2026 | |
| ASX: ALC Alcidion Group Limited | Maintained: Buy | $0.16 → $0.15 | $0.09 | +70.45% | 14 | Jul 24, 2026 | |
| ASX: MAP Microba Life Sciences Limited | Downgraded: Hold | $0.12 → $0.05 | $0.05 | +4.17% | 13 | Jul 16, 2026 | |
| ASX: CGS Cogstate Limited | Maintained: Buy | $3.20 → $3.70 | $2.50 | +48.00% | 6 | Jul 8, 2026 | |
| ASX: NEU Neuren Pharmaceuticals Limited | Maintained: Buy | $22.00 → $23.50 | $18.00 | +30.56% | 15 | Jun 29, 2026 | |
| ASX: CUV Clinuvel Pharmaceuticals Limited | Maintained: Buy | $19.00 → $17.00 | $9.06 | +87.64% | 5 | May 24, 2026 | |
| ASX: GSS Genetic Signatures Limited | Downgraded: Hold | $0.55 → $0.10 | $0.06 | +69.49% | 8 | Apr 7, 2026 | |
| ASX: IMM Immutep Limited | Downgraded: Hold | $0.65 → $0.07 | $0.05 | +52.17% | 8 | Mar 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $0.42 | $0.13 | +223.08% | 2 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $0.09 → $0.10 | $0.02 | n/a | 5 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $1.30 → $0.05 | $0.01 | n/a | 4 | Apr 1, 2025 |
CSL Limited
Jul 31, 2026
Maintained: Hold
Price Target: $100.00 → $120.00
Current: $123.06
Upside: -2.49%
PYC Therapeutics Limited
Jul 30, 2026
Maintained: Buy
Price Target: $2.30
Current: $1.70
Upside: +35.29%
Syntara Limited
Jul 28, 2026
Maintained: Buy
Price Target: $0.06
Current: $0.03
Upside: +140.00%
Alcidion Group Limited
Jul 24, 2026
Maintained: Buy
Price Target: $0.16 → $0.15
Current: $0.09
Upside: +70.45%
Microba Life Sciences Limited
Jul 16, 2026
Downgraded: Hold
Price Target: $0.12 → $0.05
Current: $0.05
Upside: +4.17%
Cogstate Limited
Jul 8, 2026
Maintained: Buy
Price Target: $3.20 → $3.70
Current: $2.50
Upside: +48.00%
Neuren Pharmaceuticals Limited
Jun 29, 2026
Maintained: Buy
Price Target: $22.00 → $23.50
Current: $18.00
Upside: +30.56%
Clinuvel Pharmaceuticals Limited
May 24, 2026
Maintained: Buy
Price Target: $19.00 → $17.00
Current: $9.06
Upside: +87.64%
Genetic Signatures Limited
Apr 7, 2026
Downgraded: Hold
Price Target: $0.55 → $0.10
Current: $0.06
Upside: +69.49%
Immutep Limited
Mar 16, 2026
Downgraded: Hold
Price Target: $0.65 → $0.07
Current: $0.05
Upside: +52.17%
Aug 7, 2025
Maintained: Buy
Price Target: $0.42
Current: $0.13
Upside: +223.08%
May 13, 2025
Maintained: Hold
Price Target: $0.09 → $0.10
Current: $0.02
Upside: n/a
Apr 1, 2025
Downgraded: Sell
Price Target: $1.30 → $0.05
Current: $0.01
Upside: n/a